Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
LM
LiNA Medical Innovation ApS
aktivCVR 36015535AnpartsselskabFormervangen 5, 2600 GlostrupFremstilling af farmaceutiske præparater
- Latest accounts
- 2026
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2026
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK -76.8k
Latest period
Source details
Source: dk-regnskabsdata-live-36015535-1793914416070
Document: dk-regnskabsdata-36015535-AaEbkN6On2nmucE3HaK7-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx1
Unit: vDKK
Net result
DKK -61.3k
Latest period
Source details
Source: dk-regnskabsdata-live-36015535-1793914416070
Document: dk-regnskabsdata-36015535-AaEbkN6On2nmucE3HaK7-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx1
Unit: vDKK
Equity
DKK -89.8k
Equity ratio: -129.1%
Source details
Source: dk-regnskabsdata-live-36015535-1793914416070
Document: dk-regnskabsdata-36015535-AaEbkN6On2nmucE3HaK7-1
XBRL: fsa:Equity
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx4
Unit: vDKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | DKK -7.9k |
| 2024 | — | DKK -18.6k |
| 2025 | — | DKK -13.8k |
| 2026 | — | DKK -61.3k |